Your session is about to expire
← Back to Search
MSCTC-0010 Dose Escalation for Graft-versus-Host Disease
Study Summary
This trial is testing if two different doses of stem cells from umbilical cords can help people with aGVHD. The first 5 people will get a lower dose, and if there are no serious problems, the next 5 will get a higher dose.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is the elderly population eligible for participation within this research endeavor?
"According to the trial's criteria, individuals between 18 and 75 are eligible for enrolment. There are 65 trials taking place for minors, and 147 studies being conducted on seniors over the age of 65."
Has the MSCTC-0010 Dose Escalation regimen been cleared by federal regulators?
"Due to the preliminary nature of the data, MSCTC-0010 Dose Escalation received a safety score of 1. This is because this phase one trial has limited clinical evidence that supports both its efficacy and risk profile."
Are there any restrictions on who may participate in this clinical experiment?
"This medical trial is recruiting 10 people diagnosed with GVHD within a specified age range (18-75). In order to meet the criteria, they must be using double contraception, have de novo HR or steroid refractory Grade II-IV aGVHD as outlined in Appendix 1 – though biopsy at screening is optional. Moreover, participants should have received an allogenic transplant from Kansas University Cancer Center/University of Kansas Medical Centre and cannot naturally postmenopausal for 12 consecutive months nor donate sperm while partaking in this study and 90 days after completing their treatment."
What is the current sample size of this research?
"Affirmative. According to clinicaltrials.gov, this research endeavour first went public on July 9th 2018 and has since been altered as recently as June 6th 2022; presently the trial is recruiting a total of 10 participants from one site."
Is the research currently in search of participants?
"According to the clinicaltrials.gov entry, this trial is actively enrolling participants as of June 6th 2022 and was first posted on July 9th 2018."
Share this study with friends
Copy Link
Messenger